Salinding, Kris Mae .
HRN: 22-09-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2023
CEFUROXIME 500MG (TAB)
02/15/2023
02/22/2023
PO
500mg Tab
BID
Post NSVD With RMLE And Repair
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes